Your browser doesn't support javascript.
loading
Neuroimaging evidence for structural correlates in adolescents resilient to polysubstance use: A five-year follow-up study.
Filippi, Irina; Galinowski, André; Lemaître, Hervé; Massot, Christian; Zille, Pascal; Frère, Pauline; Miranda-Marcos, Rubén; Trichard, Christian; Guldner, Stella; Vulser, Hélène; Paillère-Martinot, Marie-Laure; Quinlan, Erin Burke; Desrivieres, Sylvane; Gowland, Penny; Bokde, Arun; Garavan, Hugh; Heinz, Andreas; Walter, Henrik; Daedelow, Laura; Büchel, Christian; Bromberg, Uli; Conrod, Patricia J; Flor, Herta; Banaschewski, Tobias; Nees, Frauke; Heintz, Stefan; Smolka, Michael; Vetter, Nora C; Papadopoulos-Orfanos, Dimitri; Whelan, Robert; Poustka, Louise; Paus, Tomas; Schumann, Gunter; Artiges, Eric; Martinot, Jean-Luc.
Afiliación
  • Filippi I; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Galinowski A; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Lemaître H; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Massot C; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Zille P; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Frère P; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Miranda-Marcos R; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France; Hôpitaux de Paris, Department of Psychiatry and Addictology, Paul Br
  • Trichard C; Etablissement Public de Santé Barthélémy Durand, Department of Psychiatry, Étampes, France.
  • Guldner S; Central Institute of Mental Health, Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Vulser H; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Paillère-Martinot ML; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Quinlan EB; MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Desrivieres S; MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Gowland P; School of Physics and Astronomy, Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom.
  • Bokde A; Trinity College, Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Dublin, Ireland.
  • Garavan H; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.
  • Heinz A; Department of Psychiatry and Psychotherapy, Charite University Hospital Berlin, Berlin, Germany.
  • Walter H; Department of Psychiatry and Psychotherapy, Charite University Hospital Berlin, Berlin, Germany.
  • Daedelow L; Department of Psychiatry and Psychotherapy, Charite University Hospital Berlin, Berlin, Germany.
  • Büchel C; Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bromberg U; Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Conrod PJ; Sainte Justine Hospital, Department of Psychiatry, Montreal University, Montréal, Québec, Canada.
  • Flor H; Central Institute of Mental Health, Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Banaschewski T; Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute for Mental Health, Heidelberg University, Mannheim, Germany.
  • Nees F; Central Institute of Mental Health, Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Heintz S; Central Institute of Mental Health, Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Smolka M; Technische Universität Dresden, Department of Psychiatry, Dresden, Germany.
  • Vetter NC; Technische Universität Dresden, Department of Psychiatry, Dresden, Germany.
  • Papadopoulos-Orfanos D; Commissariat a l'Energie Atomique et aux Energies Alternatives Centre de Saclay, Neurospin, Saclay, France.
  • Whelan R; School of Psychology and Global Brain Health Institute, University College Dublin, Dublin, Ireland.
  • Poustka L; Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
  • Paus T; University of Toronto, Rotman Research Institute, Toronto, Ontario, Canada.
  • Schumann G; MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Artiges E; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France; GH Nord Essonne, Service de Psychiatrie 91G16, Orsay, France.
  • Martinot JL; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France; Centre de Neuro-Imagerie de Recherche, Institut du Cerveau et de la
Eur Neuropsychopharmacol ; 49: 11-22, 2021 08.
Article en En | MEDLINE | ID: mdl-33770525

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Alcoholismo Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans Idioma: En Revista: Eur Neuropsychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Alcoholismo Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans Idioma: En Revista: Eur Neuropsychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Francia